Sector Update: Health Care Stocks Lower Friday Afternoon

Health care stocks were retreating Friday afternoon, with the NYSE Health Care Index falling 1.5% and the Health Care Select Sector SPDR Fund (XLV) dropping 1.6%. The iShares Biotechnology ETF (IBB) w

MT NewswiresApr 13 01:48

Theravance Biopharma Shares Rise After BTIG Starts Coverage at Buy

Theravance Biopharma (TBPH) shares climbed 8.3% in recent Friday trading after BTIG started its coverage with a buy rating and a price target of $21. Trading volume stood at more than 330,000 shares a

MT NewswiresApr 13 00:41

Veru, Theravance Biopharma, Adial Pharmaceuticals Among Healthcare Movers

Seeking AlphaApr 12 22:00

Theravance Biopharma (TBPH.US) was first covered by BTIG and given a buy rating, with a target price of $21.00.

Theravance Biopharma (TBPH.US) was first covered by BTIG and given a buy rating, with a target price of $21.00.

Zhitong FinanceApr 12 19:50

BTIG Initiates Coverage On Theravance Biopharma With Buy Rating, Announces Price Target of $21

BTIG analyst Julian Harrison initiates coverage on Theravance Biopharma with a Buy rating and announces Price Target of $21.

Analyst UpgradesApr 12 19:42

Theravance Biopharma Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/12/2024 135.16% BTIG → $21 Initiates Coverage On → Buy 08/08/2023 123.96% HC Wainwright & Co. → $20 Rei

BenzingaApr 12 19:36